Search Results - "Akonde, Alain"
-
1
Resistance-Associated Mutations to Etravirine (TMC-125) in Antiretroviral-Naïve Patients Infected with Non-B HIV-1 Subtypes
Published in Antimicrobial Agents and Chemotherapy (01-02-2010)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
2
Incidence of lipodystrophy and metabolic disorders in patients starting non―nucleoside reverse transcriptase inhibitors in Benin
Published in Antiviral therapy (01-01-2009)“…The incidence and risk factors for lipodystrophy and metabolic disorders among patients in Africa on first-line combined antiretroviral treatment (cART) mostly…”
Get full text
Journal Article -
3
Switch to second-line ART in West African routine care: incidence and reasons for switching
Published in AIDS care (01-01-2011)“…In sub-Saharan Africa, while antiretroviral therapy (ART) becomes widely available, access to biological measurements to monitor patients under ART remains…”
Get full text
Journal Article -
4
Costing universal access of highly active antiretroviral therapy in Benin
Published in AIDS Care (Print) (01-05-2008)“…The study aimed to estimate costs of provision and access to highly active antiretroviral therapy (HAART) in order to assist in planning and resource…”
Get full text
Journal Article Conference Proceeding -
5
Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006
Published in Journal of antimicrobial chemotherapy (01-09-2008)“…Objectives To describe HIV-1 variants circulating in Mali and to estimate the rate of transmission of HIV-1 drug resistance in 2006. Patients and methods Viral…”
Get full text
Journal Article -
6
Resistance-Associated Mutations to Etravirine (TMC-125) in Antiretroviral-Naïve Patients Infected with Non-B HIV-1 Subtypes
Published in Antimicrobial agents and chemotherapy (01-02-2010)“…Susceptibility to etravirine (ETR), an expanded-spectrum nonnucleoside reverse transcriptase inhibitor (NNRTI), is dependent on the type and number of NNRTI…”
Get full text
Journal Article